Sponsor

Nsc Therapeutics GmbH

Austria Willersdorfer Strasse 7, 8061, Austria

About the sponsor

Nsc Therapeutics GmbH focuses on clinical research in Alzheimer's disease, with attention to mild to moderate cognitive impairment and symptomatic treatment domains linked to memory, attention, and daily functioning.

Muscarinic M1 receptor agonism
Cognitive symptoms in Alzheimer's disease
Neurodegenerative disorders

The sponsor’s clinical interest includes central nervous system therapies aimed at modulating cholinergic signaling in Alzheimer's disease.

About Specializations

Nsc Therapeutics GmbH runs clinical trials in conditions such as Dementia Alzheimer's type, among others.

Dementia Alzheimer's type

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Dementia Alzheimer's type

Recruiting

Registered drug

Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Trospium Chloride
Sponsor:Nsc Therapeutics GmbH

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →